JAKis can inhibit overactivation of NSMB cells, restore the imbalance of SYK and AKT phosphorylation upon BCR stimulation, and promote the equilibrium of B-cell subpopulation distributions in RA patients. This evidence concerns the gene SYK and rheumatoid arthritis.